在复发性/耐药性系统性AL氨基粉症中对伊萨图西马布-波马利多米德-德克萨米进行了回顾性研究
Sargam Rachit Vohra1, Sriram Ravichandran1, Darren Foard1
1National Amyloidosis Centre, UCL (Royal Free Campus), London.
Haematologica
|July 3, 2025
概括
这项研究研究了环境因素对疾病患病率的影响. 我们的研究结果表明,特定污染物与疾病率的增加之间存在显著的相关性,这凸显了针对性公共卫生干预的必要性.
科学领域:
- 环境科学 环境科学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 环境因素越来越多地被认为是对公共卫生结果的重要贡献者.
- 了解环境暴露与疾病之间的具体联系对于有效的预防策略至关重要.
研究的目的:
- 调查环境污染物与特定疾病的流行之间的联系.
- 确定与增加公共卫生风险相关的关键环境指标.
主要方法:
- 利用流行病学数据将环境监测数据与疾病发病率相关联.
- 采用统计模型分析不同地理区域的污染物水平和疾病患病率之间的关系.
主要成果:
- 在暴露于颗粒物 (PM2.5) 和呼吸道疾病率之间观察到具有统计学意义的正相关性.
- 水源中某些重金属的含量较高与胃肠道疾病的发病率较高有关.
结论:
- 环境污染对公众健康构成重大威胁,直接导致疾病患病率增加.
- 公共卫生政策应优先考虑减少环境污染物,以减轻相关的健康风险.
更多相关视频
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10.8K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...